| http://www.w3.org/ns/prov#value | - King, an S&P 500 Index company, seeks to capitalize on opportunities in the pharmaceutical industry through the development, including through in-licensing arrangements and acquisitions, of novel brande...Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications...very and development companies to make Hong Kong a new frontier in the biotechnology industry.
|
